Ikapharmindo Putramas Tbk. vs Reksa Dana Premier ETF IDX30 — how do they compare? Ikapharmindo Putramas Tbk. trades at Rp183 (market cap 304.92B, 13.7K 24h volume), while Reksa Dana Premier ETF IDX30 trades at Rp442 (market cap 1.81T, 40K 24h volume). The key difference: Reksa Dana Premier ETF IDX30 is far larger — about 5.9× Ikapharmindo Putramas Tbk.'s market cap, and Reksa Dana Premier ETF IDX30 is more actively traded (40K versus 13.7K). Which is the better fit depends on your goals.
| IKPM | XIIT | |
|---|---|---|
Market Cap | 304.92B | 1.81T |
Volume | 13.7K | 40K |
Lot | 137 | 400 |
Turnover | 2.49M | 17.86M |
Average Price | 181.39 | 446.61 |
Value | 2.49M | 17.86M |
Trailing returns across standard periods
Latest headlines on both assets
PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Read more on IKPM →